Boundless Bio Inc (BOLD): Next-Year EPS Estimate 46.22%
As of 2026-06-11, Boundless Bio Inc (BOLD) has a next-year EPS growth estimate of 46.22%.
On 2026-05-10, analyst consensus for BOLD's next-year EPS growth shifted from 46.15% to 46.22% — a positive change of 0.07 percentage points. The revised estimate has been sustained across 25 subsequent trading sessions. Current-year growth is projected at 8.46%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 46.22%
- EPS growth this year
- 8.46%
- EPS next quarter (est)
- -$0.60
- Last price
- $1.39
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 46.22% | 8.46% | -$0.60 | $1.39 |
| 2026-06-10 | 46.22% | 8.46% | -$0.60 | $1.38 |
| 2026-06-09 | 46.22% | 8.46% | -$0.60 | $1.40 |
| 2026-06-08 | 46.22% | 8.46% | -$0.60 | $1.43 |
| 2026-06-07 | 46.22% | 8.46% | -$0.60 | $1.42 |
| 2026-06-04 | 46.22% | 8.46% | -$0.60 | $1.47 |
| 2026-06-03 | 46.22% | 8.46% | -$0.60 | $1.44 |
| 2026-06-02 | 46.22% | 8.46% | -$0.60 | $1.43 |
| 2026-06-01 | 46.22% | 8.46% | -$0.60 | $1.44 |
| 2026-05-31 | 46.22% | 8.46% | -$0.60 | $1.45 |
| 2026-05-28 | 46.22% | 8.46% | -$0.60 | $1.46 |
| 2026-05-27 | 46.22% | 8.46% | -$0.60 | $1.47 |
| 2026-05-26 | 46.22% | 8.46% | -$0.60 | $1.47 |
| 2026-05-25 | 46.22% | 8.46% | -$0.60 | $1.44 |
| 2026-05-24 | 46.22% | 8.46% | -$0.60 | $1.44 |
| 2026-05-21 | 46.22% | 8.46% | -$0.60 | $1.45 |
| 2026-05-20 | 46.22% | 8.46% | -$0.60 | $1.42 |
| 2026-05-19 | 46.22% | 8.46% | -$0.60 | $1.40 |
| 2026-05-18 | 46.22% | 8.46% | -$0.60 | $1.42 |
| 2026-05-17 | 46.22% | 8.46% | -$0.60 | $1.49 |
| 2026-05-14 | 46.22% | 8.46% | -$0.60 | $1.55 |
| 2026-05-13 | 46.22% | 8.46% | -$0.60 | $1.53 |
| 2026-05-12 | 46.22% | 8.46% | -$0.60 | $1.50 |
| 2026-05-11 | 46.22% | 8.46% | -$0.60 | $1.55 |
| 2026-05-10 | 46.22% | 8.46% | -$0.60 | $1.44 |
| 2026-05-07 | 46.15% | 8.33% | -$0.58 | $1.53 |
| 2026-05-06 | 46.15% | 8.33% | -$0.58 | $1.58 |
| 2026-05-05 | 46.15% | 8.33% | -$0.58 | $1.57 |
| 2026-05-04 | 46.15% | 8.33% | -$0.58 | $1.57 |
| 2026-05-03 | 46.15% | 8.33% | -$0.58 | $1.57 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Boundless Bio Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Boundless Bio Inc (BOLD) has a next-year EPS growth estimate of 46.22%, based on analyst consensus.
When was the latest EPS estimate revision for BOLD?▾
The most recent revision occurred on 2026-05-10, when analysts adjusted the next-year EPS growth estimate from 46.15% to 46.22%.
What sector and industry does Boundless Bio Inc belong to?▾
Boundless Bio Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. BOLD appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Boundless Bio Inc (BOLD) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports